tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:9995 Stock Latest News

RemeGen Forecasts 2025 Profit Turnaround on Surging Drug Sales and Global Licensing Deal
Company AnnouncementsRemeGen Forecasts 2025 Profit Turnaround on Surging Drug Sales and Global Licensing Deal
24d ago
RemeGen Completes RMB20 Million A-Share Buyback for Future Equity Incentives
PremiumCompany Announcements
RemeGen Completes RMB20 Million A-Share Buyback for Future Equity Incentives
1M ago
RemeGen Raises Share Buyback Price Cap to Enable A‑Share Repurchase Plan
PremiumCompany Announcements
RemeGen Raises Share Buyback Price Cap to Enable A‑Share Repurchase Plan
1M ago
RemeGen Signs Up to US$5.6 Billion Global Licensing Deal with AbbVie for Cancer Drug RC148
PremiumCompany Announcements
RemeGen Signs Up to US$5.6 Billion Global Licensing Deal with AbbVie for Cancer Drug RC148
1M ago
RemeGen Co., Ltd. Announces A Share Repurchase Plan to Boost Employee Incentives
PremiumCompany Announcements
RemeGen Co., Ltd. Announces A Share Repurchase Plan to Boost Employee Incentives
2M ago
RemeGen Co., Ltd. Approves Key Resolutions at 2025 EGM
PremiumCompany AnnouncementsRemeGen Co., Ltd. Approves Key Resolutions at 2025 EGM
3M ago
9995
RemeGen Co., Ltd. Announces 2025 Third Extraordinary General Meeting
Premium
Company Announcements
RemeGen Co., Ltd. Announces 2025 Third Extraordinary General Meeting
3M ago
9995
RemeGen Co., Ltd. Engages in Strategic Wealth Management Transaction
Premium
Company Announcements
RemeGen Co., Ltd. Engages in Strategic Wealth Management Transaction
4M ago
9995
RemeGen Co., Ltd. Releases 2025 Q3 Unaudited Financial Report
PremiumCompany Announcements
RemeGen Co., Ltd. Releases 2025 Q3 Unaudited Financial Report
4M ago
9995
RemeGen Co., Ltd. Renews Key Connected Transactions and Adjusts Leasing Agreements
PremiumCompany Announcements
RemeGen Co., Ltd. Renews Key Connected Transactions and Adjusts Leasing Agreements
4M ago
9995
RemeGen Co., Ltd. Schedules Board Meeting to Review Q3 Results
PremiumCompany Announcements
RemeGen Co., Ltd. Schedules Board Meeting to Review Q3 Results
4M ago
9995
RemeGen Co., Ltd. Engages in Strategic Cash Management with SPDB Wealth Products
PremiumCompany Announcements
RemeGen Co., Ltd. Engages in Strategic Cash Management with SPDB Wealth Products
4M ago
9995
RemeGen Co., Ltd. Engages in Wealth Management Product Purchase
PremiumCompany AnnouncementsRemeGen Co., Ltd. Engages in Wealth Management Product Purchase
6M ago
9995
RemeGen’s Telitacicept Achieves Key Milestone in IgA Nephropathy Trial
Premium
Company Announcements
RemeGen’s Telitacicept Achieves Key Milestone in IgA Nephropathy Trial
6M ago
9995
RemeGen Co., Ltd. Updates Articles of Association Following Share Placement
Premium
Company Announcements
RemeGen Co., Ltd. Updates Articles of Association Following Share Placement
6M ago
9995
RemeGen Co., Ltd. Reports Strong Revenue Growth and Key Product Approvals in 2025
PremiumCompany Announcements
RemeGen Co., Ltd. Reports Strong Revenue Growth and Key Product Approvals in 2025
6M ago
9995
RemeGen’s RC148 Receives Breakthrough Therapy Designation for Lung Cancer Treatment
PremiumCompany Announcements
RemeGen’s RC148 Receives Breakthrough Therapy Designation for Lung Cancer Treatment
6M ago
9995
RemeGen Partners with Santen China for RC28-E Commercialization
PremiumCompany Announcements
RemeGen Partners with Santen China for RC28-E Commercialization
6M ago
9995
RemeGen’s Telitacicept Achieves Key Milestone in Sjögren’s Syndrome Treatment
PremiumCompany Announcements
RemeGen’s Telitacicept Achieves Key Milestone in Sjögren’s Syndrome Treatment
6M ago
9995
RemeGen Co., Ltd. Invests in Wealth Management Product for Strategic Cash Management
PremiumCompany AnnouncementsRemeGen Co., Ltd. Invests in Wealth Management Product for Strategic Cash Management
7M ago
9995
RemeGen Co., Ltd. Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
RemeGen Co., Ltd. Schedules Board Meeting to Review Interim Results
7M ago
9995
RemeGen Co., Ltd. Announces Successful H Shareholders Meeting with Key Resolutions Passed
Premium
Company Announcements
RemeGen Co., Ltd. Announces Successful H Shareholders Meeting with Key Resolutions Passed
7M ago
9995

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >